sell side

Coaching, board readiness, yoga and family: Axon IR chief heads off on sabbatical

Article

Coaching, board readiness, yoga and family: Axon IR chief heads off on sabbatical

Jan 30, 2024

By Garnet Roach

Inside IR at Novo Nordisk: The Ozempic and Wegovy maker propping up the Danish economy

Article

Inside IR at Novo Nordisk: The Ozempic and Wegovy maker propping up the Danish economy

Jan 16, 2024

By Garnet Roach

Pen at laptop

Article

How to get the most out of sell-side engagement

Nov 24, 2023

By Staff Writers

Man writing at desk

Article

IR has its work cut out as analyst coverage keeps falling

Nov 16, 2023

‘I’ve got a CO2 budget for travel: AstraZeneca IR head talks corporate access in the sustainability era

Article

Corporate access

‘I’ve got a CO2 budget for travel: AstraZeneca IR head talks corporate access in the sustainability era

Nov 01, 2023

By Garnet Roach

Meeting with whiteboard covered in Post-it notes

Article

How to approach your first 100 days in a new IR role

Sep 06, 2023

Nine takeaways from our webinar on investor days

Article

Corporate access

‘Fall in love with the process’: Nine takeaways from our webinar on investor days

Aug 18, 2023

Goldman Sachs cuts odds of US recession to 20 percent over the next year

Article

Goldman Sachs cuts odds of US recession to 20 percent over the next year

Jul 25, 2023

Global investors still display more fear than greed, finds Bank of America survey

Article

Shareholder targeting & ID

Global investors still display more fear than greed, finds Bank of America survey

Jul 19, 2023

Skyscrapers in Shanghai

Article

Asia-Pacific dominates IPO market in first half of 2023

Jul 05, 2023

Subscribe to sell side